Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer

Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer

<p><b>Background:</b> Immune checkpoint blockade (ICB) is arguably the greatest advance in medical oncology this century. Nonetheless, responses are highly variable. Mechanistic insights into this heterogeneity promises to improve patient stratification and identification of thera...

書目詳細資料
主要作者:	Watson, RA
其他作者:	Fairfax, B
格式:	Thesis
語言:	English
出版:	2023
主題:	Immunology Immuno-oncology Oncology, Experimental

相似書籍

Immune Checkpoint Blockade sensitivity and Progression-Free Survival associates with baseline CD8+ T cell clone size and cytotoxicity
由: Watson, R, et al.
出版: (2021)

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
由: Sharmila Nair, et al.
出版: (2021-01-01)

Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma
由: Tong, O
出版: (2023)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
由: Cristina Valero, et al.
出版: (2023-10-01)

Mathematical modelling and transcriptional characterisation of intratumoral regulatory T cell sub-populations
由: Muzhingi, I
出版: (2023)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
由: Robert W. Wilkinson, et al.
出版: (2018-06-01)

New approaches to treating cancer using immune-checkpoint blockade
由: Fellermeyer, M
出版: (2023)

FcγRIIB is a T cell checkpoint in antitumor immunity
由: Clara R. Farley, et al.
出版: (2021-02-01)

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
由: Jun Gong, et al.
出版: (2018-10-01)

Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)
由: Vassilis Genoud, et al.
出版: (2021-11-01)

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
由: Joseph S. Dolina, et al.
出版: (2023-09-01)

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
由: Xiaoxin Ren, et al.
出版: (2022-11-01)

A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity
由: Nadine Nelson, et al.
出版: (2019-08-01)

IL-1 receptor–associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
由: Gürcan Tunalı, et al.
出版: (2023-04-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
由: Virginia Laspidea, et al.
出版: (2022-04-01)

EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice
由: Armin Rehm, et al.
出版: (2022-06-01)

Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells
由: Xinyi Jiang, et al.
出版: (2023-05-01)

CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
由: Madhura Modak, et al.
出版: (2022-06-01)

Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
由: Kentaro Masuhiro, et al.
出版: (2022-05-01)

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
由: Colt A. Egelston, et al.
出版: (2022-02-01)

CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
由: Miriam Y. Kim, et al.
出版: (2021-08-01)

Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models
由: Xiang Li, et al.
出版: (2023-04-01)

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
由: Michael Brandon Ware, et al.
出版: (2023-04-01)

Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases
由: Jessica Tsukamoto, et al.
出版: (2018-10-01)

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
由: Elizabeth Comen, et al.
出版: (2024-02-01)

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
由: Tiina E. Kähkönen, et al.
出版: (2021-06-01)

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
由: Gabrielle Romain, et al.
出版: (2022-09-01)

Editorial: Tumor microenvironment complexity and its therapeutic implications
由: Denner Santos dos Anjos, et al.
出版: (2025-01-01)

CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
由: Kathryn E. Beckermann, et al.
出版: (2020-08-01)

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach
由: Gillian Murtagh, et al.
出版: (2024-02-01)

PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors
由: Rebekka Duhen, et al.
出版: (2022-06-01)

Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients
由: Max M. Wattenberg, et al.
出版: (2021-03-01)

Immune regulatory networks in inflammation-driven cancer
由: Franchini, F
出版: (2017)

Immune determinants of Barrett’s progression to esophageal adenocarcinoma
由: Kiran H. Lagisetty, et al.
出版: (2021-01-01)

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells
由: Spencer E. Brightman, et al.
出版: (2023-01-01)

CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer
由: Masayo Ukita, et al.
出版: (2022-06-01)

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
由: Alessandro Mega, et al.
出版: (2023-12-01)

IL-32γ potentiates tumor immunity in melanoma
由: Thomas Gruber, et al.
出版: (2020-09-01)

Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC
由: Eric Tu, et al.
出版: (2022-02-01)

A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
由: Diana I. Albu, et al.
出版: (2024-12-01)